JUPW
NASDAQ:JUPW
Jupiter Wellness, Inc.
- Stock
1.52
+11.76%
0.16
news - Feb 10, 2024 - 00:25
Jupiter Wellness (NASDAQ:JUPW) Stock Price Down 0.8% - American Banking and Market News
The article discusses a decrease of 0.8% in the stock price of Jupiter Wellness (NASDAQ:JUPW).
americanbankingnews.comnews - Aug 18, 2023 - 12:00
UFC Marital Artist and Influencer Hector Lombard Signs on
UFC Marital Artist and Influencer Hector Lombard Signs on. The worlds first blood alcohol detox drink to launch Q4 2023. Safety Shot is created by a doctor, patented and validated by research.
globenewswire.comnews - Aug 03, 2023 - 20:55
Jupiter Wellness, Inc. Announces Temporary Postponement of
Jupiter Wellness, Inc. Announces Temporary Postponement of. Distribution of shares of common stock, par value $0.0001 per share (SRM Common Stock), to effect the spin-off of the SRM business has been delayed. The Company remains intent on effectuating the distribution as soon as practicable.
globenewswire.comnews - Jul 11, 2023 - 20:05
Jupiter Wellness, Inc. Announces Postponement of Spin-Off
Jupiter Wellness, Inc. Announces Postponement of Spin-Off. Company remains intent on effectuating the distribution as soon as it may do so in compliance with federal securities laws and appropriate regulatory approval.
globenewswire.comnews - Jun 27, 2023 - 21:29
Jupiter Wellness, Inc. Announces Record Date for Spin-Off
The record date for the spin-off and distribution of shares of common stock, par value $0.0001 per share, of SRM Entertainment, Inc. (SRM), currently a majority-owned subsidiary of the Company, has been set for July 7, 2023 (the Record Date) Stockholders of Jupiter Wellness and holders of certain warrants issued in the Companys public offering in July 2021 ( the Warrants) will receive one share SRm Common Stock, for every 19.35 shares. The distribution is expected to paid on or about July 12,2023, subject to SRMs Registration Statement on Form S-1, being declared effective by the SEC.
globenewswire.comDescription
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus